University of Queensland researchers have examined taste and smell genes to help determine whether specific foods cause or are linked to disease. People who like the taste and smell of onions are more likely to have lower ...
5 hours ago
0
0
Orforglipron is beneficial for blood glucose control in individuals with type 2 diabetes using metformin or taking insulin glargine, according to two studies published online June 8 in The Lancet and the JAMA to coincide ...
6 hours ago
0
0
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have become popular for weight loss, but results vary from person to person and from drug to drug. Venky Soundararajan and colleagues explored the full range of responses ...
7 hours ago
0
1
A major Australian clinical trial has found that timing when you eat can be just as effective as traditional dietitian-led advice in trying to lower the risk of developing type 2 diabetes.
13 hours ago
0
4
The U.S. Food and Drug Administration (FDA) has cleared the first over-the-counter wearable device to track blood sugar in young children.
Jun 15, 2026
0
1
Among patients with preexisting hypertension taking antihypertensive medications, glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with an increase in hypotensive-related events, according to a study ...
Jun 15, 2026
0
3
A clinical trial supported by the National Institutes of Health (NIH) found that adults with prediabetes assigned to a lifestyle intervention had a significantly lower risk of developing multiple chronic health conditions ...
Jun 15, 2026
0
1
One of the largest real-world studies of people taking GLP-1 medications found women, those without pre-existing conditions such as type 2 diabetes and high blood pressure, and behavioral factors such as previously setting ...
Jun 15, 2026
0
2
Tirzepatide doesn't just help people lose weight; it also activates brown adipose tissue, representing a major milestone in obesity research, according to a study presented at ENDO 2026, the Endocrine Society's annual meeting ...
Jun 15, 2026
0
3
Researchers are warning that obesity is reshaping the global cardiovascular disease crisis, as trend data covering 204 countries reveal that heart disease now peaks in people ages 50–54 rather than the elderly and increasingly ...
Jun 15, 2026
0
2
